J. Goldman & Co’s Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant CPUH.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-96,380
Closed -$965K 479
2021
Q3
$965K Sell
96,380
-10,400
-10% -$104K 0.05% 241
2021
Q2
$1.09M Hold
106,780
0.04% 275
2021
Q1
$1.08M Buy
+106,780
New +$1.12M 0.03% 299

Other funds holding CPUH.U

J. Goldman & Co's CPUH.U Position: Q4 2021 in Review

J. Goldman & Co sold out of Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant (CPUH.U) in Q4 2021, closing a stake of 96,380 shares — an estimated $965K sold.

J. Goldman & Co first reported a position in CPUH.U in Q1 2021 and held it in 3 quarters. The position peaked at $1.09M in Q2 2021. 42 funds tracked by Wall St. Rank hold CPUH.U as of Q4 2021.

  • J. Goldman & Co reported no remaining Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant position as of Q4 2021 after selling out during the quarter.
  • J. Goldman & Co sold 96,380 Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant shares in Q4 2021, an estimated $965K.
  • J. Goldman & Co first reported a position in Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant in Q1 2021 and held it in 3 quarters.
  • J. Goldman & Co's Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant position peaked at $1.09M in Q2 2021.
  • 42 funds tracked by Wall St. Rank held Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant as of Q4 2021.

Based on J. Goldman & Co's 13F filing for Q4 2021, filed 14 Feb 2022.